The multiple antibiotic resistance operon of enteric bacteria controls DNA repair and outer membrane integrity by Sharma, Prateek et al.
 
 
The multiple antibiotic resistance operon of enteric
bacteria controls DNA repair and outer membrane
integrity
Sharma, Prateek; Haycocks, James; Middlemiss, Alistair; Kettles, Rachel; Sellars, Laura;
Ricci, Vito; Piddock, Laura; Grainger, David
DOI:
10.1038/s41467-017-01405-7
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Sharma, P, Haycocks, J, Middlemiss, A, Kettles, R, Sellars, L, Ricci, V, Piddock, L & Grainger, D 2017, 'The
multiple antibiotic resistance operon of enteric bacteria controls DNA repair and outer membrane integrity',
Nature Communications, vol. 8, no. 1, 1444 (2017). https://doi.org/10.1038/s41467-017-01405-7
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 31/11/2017
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
ARTICLE
The multiple antibiotic resistance operon of enteric
bacteria controls DNA repair and outer membrane
integrity
Prateek Sharma1, James R.J. Haycocks1, Alistair D. Middlemiss 1, Rachel A. Kettles1, Laura E. Sellars1,
Vito Ricci2, Laura J.V. Piddock 2 & David C. Grainger1
The multiple antibiotic resistance (mar) operon of Escherichia coli is a paradigm for chro-
mosomally encoded antibiotic resistance in enteric bacteria. The locus is recognised for its
ability to modulate efﬂux pump and porin expression via two encoded transcription factors,
MarR and MarA. Here we map binding of these regulators across the E. coli genome and
identify an extensive mar regulon. Most notably, MarA activates expression of genes required
for DNA repair and lipid trafﬁcking. Consequently, the mar locus reduces quinolone-induced
DNA damage and the ability of tetracyclines to traverse the outer membrane. These pre-
viously unrecognised mar pathways reside within a core regulon, shared by most enteric
bacteria. Hence, we provide a framework for understanding multidrug resistance, mediated
by analogous systems, across the Enterobacteriaceae. Transcription factors MarR and MarA
confer multidrug resistance in enteric bacteria by modulating efﬂux pump and porin
expression. Here, Sharma et al. show that MarA also upregulates genes required for lipid
trafﬁcking and DNA repair, thus reducing antibiotic entry and quinolone-induced DNA
damage.
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The Escherichia coli multiple antibiotic resistance (mar)locus was identiﬁed as a determinant for cross-resistance totetracyclines, quinolones and β-lactams1. Widespread
among enteric bacteria, the system confers clinically relevant
antimicrobial resistance in E. coli2–6. The mar phenotype results
from induction of an operon designated marRAB7. In wild-type
cells, marRAB expression is stochastic and enhanced by many
antimicrobial compounds7, 8. Conversely, in some clinical iso-
lates, marRAB expression is constitutive; mutations prevent auto-
repression by MarR7, 9. Induction of marRAB results in expres-
sion of MarA, a transcription factor that controls multidrug efﬂux
and porin production9–13. Like all members of the AraC-XylS
family, MarA uses a dual helix-turn-helix motif to bind non-
palindromic DNA targets14. This DNA sequence, called the
‘marbox’, is conserved in Gram-negative bacteria14, 15. Proteins
related to MarA, such as SoxS, Rob and RamA, also recognise the
marbox and have overlapping regulatory effects15–17. However,
interplay between these factors is complex. For example, Rob
binds DNA with low speciﬁcity, but high afﬁnity, and is usually
sequestered in a non-functional state18, 19. Conversely, MarA and
SoxS have a lower afﬁnity for the marbox but form ternary
complexes with RNA polymerase that enhance recognition of
marbox-containing promoters19. It is likely that Rob behaves
differently to other marbox binding proteins because Rob has a
multimerisation domain and can interact with DNA using only
one of its two helix-turn-helix motifs18–20.
Models that depend on drug efﬂux and reduced porin pro-
duction cannot explain all mar phenotypes21, 22. For example,
substantial resistance to minocycline is retained in ΔmarR cells
lacking tolC or acrAB22. Such observations have stimulated
attempts to deﬁne the complete MarA regulon. Transcriptome
analyses identiﬁed hundreds of genes putatively controlled by
MarA23, 24. However, only three genes were common to inde-
pendent studies16. Similarly, while 10,000 copies of the marbox
occupy the E. coli genome, most are non-functional19, 25. Con-
sequently, only a handful of experimentally conﬁrmed MarA
binding sites are listed in the Ecocyc database (Supplementary
Table 1)26.
In this work, we have mapped genome-wide DNA binding by
both MarR and MarA using chromatin immunoprecipitation and
DNA sequencing (ChIP-seq). We show that the mar regulon is
extensive and encompasses both DNA repair and lipid trafﬁcking
systems. These regulatory events allow the mar locus to combat
quinolone-induced DNA damage and penetration of the outer
membrane by antimicrobial compounds. Although previously
unrecognised, these pathways reside within a ‘core’ mar regulon
shared by many enteric bacteria.
Results
Genome-wide distribution of marRAB-encoded transcription
factors. We used ChIP-seq to map global DNA binding by the
marRAB-encoded transcription factors and the RNA polymerase
σ70 subunit. Experiments were done using the enterotoxigenic E.
coli strain H1040727. The strain shares 3766 genes with E. coli K-
12 and has 599 additional genes encoded by 25 discrete chro-
mosomal loci and 4 plasmids (p948, p666, p58 and p52). We
expected to identify a primary mar regulon, shared by most E. coli
species, and additional targets speciﬁc to toxigenic strains. The
MarA, MarR and σ70 binding proﬁles of are shown in Fig. 1a. In
each plot, genes are illustrated by blue lines (tracks 1 and 2),
MarA binding is in green (track 3), σ70 binding is in orange (track
4) and MarR binding is in black (track 5). As expected, MarR
bound only to the marRAB promoter while MarA and
σ70 bound at many loci. We used MEME to identify sequence
motifs associated with the 33 MarA binding peaks. Only one
statistically signiﬁcant (E-value< 1e−12) motif was found
(Fig. 1b, top panel). The motif closely resembles known MarA
binding sites (Fig. 1b, compare top and bottom panel). For all
peaks we determined the distance to the nearest start codon and
sorted these distances into 100 bp bins. The distribution of peaks
among the bins is illustrated in Fig. 1c; MarA and σ70 most
frequently bind the 100 bp preceding the 5′ end of a gene. Of the
33 MarA binding peaks, 15 were within 150 bp of a binding peak
for σ70 (Fig. 1c, inset). To support our ChIP-seq analysis, we
tested binding of puriﬁed MarA to DNA fragments overlapping
all 33 peaks. As a control, we also tested ﬁve DNA fragments from
elsewhere in the genome. All but one of the DNA sequences
derived from MarA ChIP-seq peaks bound MarA in vitro
(Supplementary Fig. 1a). However, there was no binding to any of
the control sequences (Supplementary Fig. 1b). The ChIP-seq and
in vitro DNA binding data are summarised in Table 1. Five MarA
targets were speciﬁc to E. coli H10407. Of these targets, one did
not bind MarA in vitro, four were within prophage remnants, and
only one was near to the 5′ end of a gene. Note that our list of
MarA targets will not include sites occluded by other proteins
in vivo28. For example, most known marboxes preferentially bind
SoxS or Rob; we did not expect to isolate these loci
(Supplementary Table 1)19. Consistent with this, our ChIP-seq
identiﬁed only the known marboxes with a high afﬁnity for MarA
(Supplementary Table 1).
Phenotypic landscape of the mar regulon. We focused on the 28
MarA binding sites shared with E. coli K-12. Implications for
antibiotic resistance were assessed using phenotypic proﬁling data
(Fig. 1d; Supplementary Fig. 2)29. In the heatmap, rows represent
E. coli strains lacking individual MarA-targeted genes. Columns
indicate treatment with different antibiotics. Where columns and
rows intersect boxes are coloured according to growth relative to
wild-type cells. Hence, red boxes identify MarA targets required
for innate resistance to the corresponding antibiotic. Of particular
note are xseA and the mlaFEDCB operon. These encode the large
subunit of exonuclease VII and a lipid trafﬁcking ABC transport
system, respectively30–32. The data indicate that xseA is a
determinant for quinolone tolerance. Conversely, mlaFEDCB
mediates sensitivity to several antibiotics including tetracyclines
(Fig. 1d).
PxseA is a MarA-activated promoter. Figure 2a shows
co-binding of MarA and RNA polymerase to the xseA locus. The
sequence of the regulatory region is in Fig. 2b. The putative
marbox (green) is immediately adjacent to the xseA promoter
(PxseA; orange)33. To conﬁrm binding at the marbox, we used
electrophoretic mobility shift assays (EMSA) and DNAseI foot-
printing. For the EMSA experiments we used the xseA1 and
xseA2 DNA fragments; the 5′ end of each fragment is denoted by
an inverted triangle in Fig. 2b. The −36C mutation, present only
in xseA2, ensures marbox inactivation. The EMSA experiment is
shown in Fig. 2c. As predicted, MarA bound to the xseA1 frag-
ment (top panel) but not the xseA2 fragment (bottom panel). In
DNAseI footprinting, MarA protects the marbox from digestion
and induces hypersensitivity at adjacent sites (Fig. 2d). The xseA1
and xseA2 fragments were also fused to lacZ in the reporter
plasmid pRW50. Measurements of β-galactosidase activity sug-
gest a role for the marbox in transcription activation (Fig. 2e).
Consistent with this, raising the intracellular concentration of
MarA stimulates PxseA only in the presence of the marbox
(Supplementary Fig. 3). Note that this approach avoids deletion
of marA and the possibility of compensatory regulation by SoxS
or Rob.
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Fig. 1 Global analysis of MarA and its target genes. a Genome-wide distribution of MarA, MarR and RNA polymerase in enterotoxigenic Escherichia coli
strain H10407. Plots are shown for the H10407 chromosome and four plasmids. In each plot, the tick mark at the 12 o’clock position represents the ﬁrst
base pair (bp) of the DNA element. Subsequent tick marks are spaced by 1 Mbp (chromosome) 10 Kbp (p948 and p666) or 1 Kbp (p58 and p52). In each
plot, tracks 1 and 2 (blue lines) show the position of genes, track 3 (green) is the MarA binding proﬁle, track 4 (orange) is the RNA polymerase σ70 subunit
binding proﬁle and track 5 (black) is the MarR binding proﬁle. b DNA sequence motifs recovered from MarA binding peaks. The top panel shows a DNA
sequence motif identiﬁed by MEME present in DNA sequences associated with MarA in ChIP-seq analysis. The bottom panel shows a DNA sequence
motif generated by aligning experimentally veriﬁed MarA binding sites listed in Ecocyc. c Location of MarA and RNA polymerase binding peaks with
respect to genes. A histogram depicting the distance between ChIP-seq binding peaks and the nearest 5′ end of a gene; data for MarA binding are in green
and data for σ70 binding are in orange. Each binding peak was allocated to a series of 100 bp bins. The inset is a Venn diagram that illustrates the number of
MarA and σ70 binding peaks that overlap. d Phenotypic landscape of the MarA regulon. The heatmap illustrates ﬁtness scores29 of strains lacking MarA
target genes (y-axis) compared to the wild-type parent strain. Strains were grown in the presence of different antibiotics (x-axis). The antibiotics are
clustered according to the cellular process targeted (labelled above heatmap). Drugs are further divided into classes i through x by yellow dotted lines. The
classes are as follows: i quinolones, ii non-quinolone topoisomerase inhibitors, iii antifolates, iv macrolides; v aminoglycosides, vi tetracyclines, vii
penicillins, viii cephalosporins, ix other cell envelope antibiotics, x miscellaneous. Individual row and column names are provided in Supplementary Fig. 2
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Activation of xseA mediates innate ciproﬂoxacin resistance.
Consistent with previous observations, the minimum inhibitory
concentration (MIC) of ciproﬂoxacin decreased in cells lacking
xseA (Supplementary Table 2). To determine if the ciproﬂoxacin
hypersensitivity phenotype was dependent on both xseA and the
marbox, we used genetic complementation. Hence, we con-
structed derivatives of plasmid pBR322 encoding xseA down-
stream of PxseA. This plasmid was able to rescue growth of an
xseA::kan E. coli strain in the presence of ciproﬂoxacin but
pBR322 with no insert was not (Supplementary Fig. 4). In the
absence of ciproﬂoxacin, deletion of the marbox had little effect
(Fig. 2f, top). However, in the presence of ciproﬂoxacin, the
marbox was essential for growth (Fig. 2f, bottom).
Innate ciproﬂoxacin resistance requires canonical XseA activ-
ity. Exonuclease VII comprises large and small subunits; XseA
and XseB, respectively. However, MarA binding was only detec-
ted upstream of xseA (Table 1). Hence, XseA could act inde-
pendently of XseB to increase quinolone tolerance. Brieﬂy, XseA
consists of four functional regions: an N-terminal OB-fold, a
central catalytic domain, a coiled-coil and a short C-terminal
domain (Supplementary Fig. 5a)34. The OB-fold is responsible for
DNA binding, the catalytic domain mediates exonuclease activity,
the coiled-coil binds XseB and the C-terminal domain contains
three α-helices34. To investigate the role of these activities, we
introduced point mutations at key positions in xseA encoded by
pBR322. The mutations, previously characterised by Poleszak
et al.34 are described in Supplementary Fig. 5a. Inactivation of any
xseA determinant required for exonuclease VII function, includ-
ing the interaction between XseA and XseB, results in hyper-
sensitivity to ciproﬂoxacin (Supplementary Fig. 5b). Consistent
with this, Nichols et al.29 also concluded that both components of
exonuclease VII were required for innate levels of ciproﬂoxacin
resistance. We conclude that XseA acts via its described exonu-
clease VII activity in our assays.
Cells lacking MarA-controlled xseA acquire DNA strand
breaks. Exonuclease VII is known to inﬂuence DNA repair35, 36.
Hence, the simplest interpretation of our data is that MarA
activates xseA to reduce DNA damage. We tested this prediction
by visualising DNA damage in Hoechst-stained E. coli cells37. As
expected, in the presence of ciproﬂoxacin, xseA::kan cells were
Table 1 MarA binding sites identiﬁed by ChIP-seq
ChIP peaka MEME site centreb Site sequence (5′–3′)c H10407 genesd MG1655 genese MarA binding
in vitrof
Chromosomal targets
206 161 gcacagacagataaa ETEC0001 thrL +++
87300 87344 gcacaattagctaat ETEC0074<>ETEC0075 leuL<>leuO +++
184212 184180 gcgttatctgttaat ETEC0157 degP ++
428898 428876 gcataaagtgtaaag ETEC0400 lacZ ++
529310 529338 gcacaaaatgacaaa ETEC0500 ybaO +++
655542 655557 gcactaaatgttaaa ETEC0604 pheP +++
846408 846418 ccacgcaaagctgac ETEC0765<>acrZ modE<>acrZ ++
963300 963348 cctatgagcgtaaaa ETEC0889 ybiV +
994036 994060 gcattaattgctaaa ETEC0916<>ETEC0917 grxA<>ybjC +++
1354006 1354020 gcactaattgcaaaa ETEC1264<>ETEC1265 ycgF<>ycgZ +++
1536992 1537038 gcacaaattgtttaa ETEC1438 fnr ++
1717096 1717112 gcactaattgctaaa ETEC1580 yneO +++
1739002 1739016 ccacgttttgctaaa ETEC1599<>ETEC1600 marC<>marR +++
2321000 2321062 gcactatttgctaaa ETEC2157 yeeF +++
2538709 2538641 gcactgaatgtcaaa ETEC2344<>micF ompC<>micF ++
2727890 2727941 gcattttttgctaaa ETEC2509 ypeC +++
2755444 2755459 gcaacaactgttaaa ETEC2533><ETEC2534 yfeS><cysM +++
2887268 2887307 gcattttttgcaaaa ETEC2665<>ETEC2666 guaB<>xseA +++
3455714 3455708 ccaatatccggcaaa ETEC3200 ETEC speciﬁc -
3569696 3569763 gcacgtaacgccaac ETEC3306<>ETEC3307 nudF<>tolC ++
3695690 3695710 gcacaatctgcttac (ETEC3426) (yhbV) +++
3733124 3733195 ccagctttcgctaac ETEC3460<>ETEC3461 mlaF<>yrbG +++
4289772 4289787 gcacgaaacgttaaa ETEC3977<>ETEC3978 ibpA<>yidQ ++
4348148 4348176 gcacgatctgtatac ETEC4032 mnmG ++
4494984 4495025 ccgctttacggtaaa (ETEC4151) (yihT) ++
4510208 4510184 gcgcgttatgctgac (ETEC4166) (yiiG) ++
4685066 4685041 aggctaatcgtataa (ETEC4304) ETEC speciﬁc +++
4686378 4686377 ccaaaaacaggtaaa (ETEC4307) ETEC speciﬁc ++
4737304 4737238 gcaataaaagtcacg ETEC4370<>ETEC4371 yjcB<>yjcC ++
5066076 5066105 gcatcaaatgataac ETEC4666<>ETEC4667 yjjP<>yjjQ +++
5093964 5093988 ccgataaatgcgaaa ETEC4702 ETEC speciﬁc ++
5132420 5132347 gcaggaagcggcgaa ETEC4739 deoB ++
Plasmid p948 targets
65178 65159 gcattttctgtcaaa ETECp9480770 ETEC speciﬁc +++
aGenome coordinate of MarA ChIP-seq peak centre in H10407. Bold type indicates peaks within 150 bp of a σ70 binding peak
bGenome coordinate of MarA binding site predicted by MEME
cSequence of MarA binding site predicted by MEME
dNearest gene to MarA binding site. Some MarA targets were between divergent (<>) and convergent (><) genes. Genes in parentheses indicate that the ChIP-seq peak is located within that gene
eE. coli K-12 homologues of ETEC genes in the previous column. E. coli K-12 MarA binding sites, listed in the Ecocyc database, are highlighted according to experimental conﬁrmation (solid line) or
prediction (dashed line)
fIn vitro binding of puriﬁed MarA observed at a concentration of 0.3 μM (+++), 1.0 μM (++) or 1.7 μM (+) (Supplementary Fig. 1a). Note that ﬁve control DNA fragments (cydD, ybiS <>ybiT, ETEC2117,
cyoA and PestA) did not bind MarA at any of these concentrations (Supplementary Fig. 1b)
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ﬁlamentous with abnormal nucleoid morphology (Fig. 2g,
compare top two panels). Plasmid pBR322 encoding xseA was
able to negate this phenotype, while deletion of the PxseA marbox
blocked complementation (Fig. 2g, bottom two panels). We
conﬁrmed that the unusual nucleoid morphology was indicative
of DNA fragmentation using pulse ﬁeld gel electrophoresis
(PFGE) (Fig. 2h). Chromosomal DNA ran as a tight band (lanes
1–3) but smearing was evident upon ciproﬂoxacin treatment of
cells lacking xseA (lanes 4, 5). As in the microscopic analysis,
genetic complementation required an intact marbox (lanes 6, 7).
For direct comparison, lanes 3, 5, 6 and 7 equate to the top
through bottom panels in Fig. 2g, respectively.
Transcription of the mla operon is activated by MarA. We next
turned our attention to the mlaFEDCB locus that also co-binds
MarA and σ70 (Fig. 3a). We conﬁrmed binding of MarA to the
mlaFEDCB regulatory DNA using EMSA and DNAse I
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footprinting assays (Fig. 3c, d). The experiments were done using
the mlaF1 and mlaF2 DNA fragments. The 5′ end of each frag-
ment is marked by an inverted triangle in Fig. 3b. The results are
consistent with MarA binding to the predicted marbox (green in
Fig. 3b). However, the location of nearby promoters is unknown.
To identify MarA regulated promoters, we used in vitro tran-
scription assays. A DNA fragment containing the mlaFEDCB
intergenic region was cloned upstream of the λoop terminator in
plasmid pSR. The resulting plasmid was used as a template for
RNA synthesis (Fig. 3e). Note the 108 nt RNAI transcript is
derived from the plasmid replication origin and serves as an
internal control. Transcripts of 128, 148 and 157 nt in length were
also observed (Fig. 3e). These initiate within the mlaFEDCB
intergenic DNA at sites denoted by a bent arrow (Fig. 3b). Each
messenger RNA start site maps downstream of promoter −10 and
−35 elements. We refer to the promoters as mlaP1, mlaP2 and
mlaP3 (Fig. 3b). MarA activates mlaP2 by binding adjacent to the
−35 hexamer (Fig. 3b, e). Hence, deletion of the marbox reduces
transcription derived from the mlaFEDCB intergenic region in
lacZ fusion assays (Fig. 3f). Similarly, MarA overproduction
activated mlaFEDCB only in the presence of the marbox (Sup-
plementary Fig. 3). Inactivation of mlaP1, which overlaps mlaP2
and the marbox, increased the stimulatory effect of the marbox
on mlaP2 activity (Supplementary Fig. 6).
Activation of mlaFEDCB mediates innate doxycycline resis-
tance. We quantiﬁed an eight-fold reduction in doxycycline MIC
for mlaE::kan compared to wild-type cells (Supplementary
Table 2). To conﬁrm that doxycycline hypersensitivity was
dependent on both mlaFEDCB and the marbox, we used genetic
complementation. Thus, we constructed derivatives of plasmid
pBR322 carrying mlaFEDCB and the upstream regulatory DNA.
This plasmid was able to rescue growth of BW25113 mlaE::kan
cells in the presence of doxycycline (Supplementary Fig. 7). As
expected, deletion of the marbox had little effect in the absence of
doxycycline (Fig. 3g, left). Conversely, in the presence of dox-
ycycline, the marbox was essential for growth (Fig. 2g, right).
Cells lacking mlaFEDCB have defective barrier function. In
Gram-negative bacteria, cell surface barrier function relies on
outer membrane asymmetry; the inner and outer leaﬂets com-
prise phospholipids and lipopolysaccharides, respectively. The
ABC transport system encoded by mlaFEDCB removes unwanted
phospholipids from the outer leaﬂet32. Hence, mlaFEDCB could
enhance drug resistance by improving outer membrane barrier
function. Alternatively, ABC transport activity could support
drug efﬂux32. To assess these hypotheses, we compared drug
accumulation and efﬂux in wild-type and mlaE::kan cells.
Accumulation increased dramatically upon disruption of mlaE
(Fig. 3h), but efﬂux was identical in both strains (Fig. 3i). Hence,
our data are consistent with increased cell surface permeability
but not defective efﬂux.
Cells lacking mlaFEDCB have increased surface hydro-
phobicity. Our model predicts reduced barrier function due to
accumulation of phospholipids in the outer leaﬂet of the outer
membrane. This should coincide with increased cell surface
hydrophobicity. To test this, we measured partitioning of wild-
type and mlaE::kan cells in a two solvent system (aqueous PUM
buffer and p-xylene)38. In this assay, cells with increased surface
hydrophobicity migrate to the organic phase. Consequently,
turbidity of the aqueous phase is reduced. Consistent with this,
mlaE::kan cells were retained in aqueous suspension less efﬁ-
ciently than the parent strain (Fig. 3j). Similar results were
obtained in crystal violet adsorption assays39; the hydrophobic
dye was bound more efﬁciently by the mlaE::kan strain (Fig. 3k).
As expected, similar phenotypes arose in complementation
experiments if the marbox was deleted in the pBR322 derivative
carrying mlaFEDCB (Supplementary Fig. 8).
SoxS and Rob binding to the xseA and mlaFEDCB promoters.
The SoxS and Rob proteins share 42 and 43% sequence identity
with MarA across their helix-turn-helix determinants, respec-
tively. Rob usually binds marboxes with a higher afﬁnity than
either MarA or SoxS19. Indeed, Rob can bind DNA fragments
containing no marbox more tightly than MarA and SoxS bind
canonical targets19. Hence, we next sought to better understand
the comparative afﬁnity of MarA, SoxS and Rob for the xseA and
mlaFEDCB promoters. In control experiments, we conﬁrmed that
Rob had appreciable non-speciﬁc DNA binding activity (Sup-
plementary Fig. 9a) and also bound a known marbox with higher
afﬁnity than MarA or SoxS (Supplementary Fig. 9b)19. Interest-
ingly, most well-deﬁned marboxes preferentially bind SoxS rather
than MarA (Supplementary Table 1). This was not the case for
the xseA or mlaFEDCB promoters, which bound MarA but not
SoxS (Supplementary Fig. 10).
The mar regulon is conserved among the Enterobacteriaceae.
Overexpression of MarA-like regulators is associated with clini-
cally relevant resistance to quinolones and tetracyclines in many
enteric bacteria40. Hence, we quantiﬁed conservation of MarA
targets among the Enterobacteriaceae. The result of the analysis is
illustrated in Fig. 4. As expected, MarA binding sites associated
with efﬂux systems and porin expression were found in most
species. The xseA marbox was similarly distributed. However, the
best conserved marbox occurred upstream of mlaFEDCB; this
Fig. 2 MarA binding upstream of xseA is important for DNA repair in the presence of ciproﬂoxacin. a ChIP-seq data for MarA and σ70 binding to the xseA
locus. Data have been smoothed in a 100 bp window. b DNA sequence upstream of xseA (start codon in blue) is shown. Relevant DNA elements are
labelled and arrows indicate orientation. The xseA transcription start (+1) was identiﬁed by Davies and Drabble33. The 5′ end of the xseA1 and xseA2 DNA
fragments are indicated by inverted black triangles. The xseA2 fragment carries the −36C mutation. c Electrophoretic mobility shift assays with the xseA1
fragment (+marbox) and the xseA2 fragment (−marbox). MarA was at a concentration of 0.3, 1.0 and 1.7 μM. d DNAseI footprinting experiment, using the
xseA1 fragment, calibrated with a Maxam–Gilbert GA sequencing ladder. Positions relative to the xseA transcription start site (+1) are labelled.
Concentrations of MarA are 0.3, 1.0, 1.7, 2.4 and 3.3 μM. The marbox is indicated by a green line. e Result of a β-galactosidase assay using lysates of
JCB387 cells transformed with a reporter plasmid where lacZ expression is controlled by either xseA1 (+marbox) or xseA2 (−marbox). Error bars show
standard deviation (n= 3). f The graph shows OD650 values obtained for cultures of strain BW25113 xseA::kan grown in the presence or absence of 0.005
μg/ml ciproﬂoxacin. The BW25113 xseA::kan cells were transformed with pBR322 derivatives encoding xseA under the control of either the xseA1 fragment
(+marbox) or the xseA2 fragment (−marbox). Error bars show standard deviation (n= 3). g Hoechst-stained BW25113 cells or the xseA::kan derivative. The
term ‘complement’ denotes BW25113 xseA::kan transformed with pBR322 encoding xseA under control of the xseA1 fragment (+marbox) or the xseA2
fragment (−marbox). The scale bar is 5 μm and all panels are the same scale. h A pulse ﬁeld gel electrophoresis experiment to analyse chromosomal
integrity of BW25113 (WT) or the xseA::kan derivative (Δ). The xseA::kan derivative of BW25113 was transformed with either empty pBR322 (Δ1), pBR322
encoding xseA under the control of xseA1 fragment (Δ2) or xseA2 (Δ3)
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sequence was present in all but the most divergent Cedecea neteri
genome. Overall, the E. coli MarA regulon is best conserved
among Escherichia spp. and Shigella spp. However, a core regulon
is shared by many Enterobacteriaceae. For example, Salmonella,
Citrobacter, Klebsiella, Enterobacter and Raoultella spp. share a
similar subset of MarA target genes including tolC, micF, xseA
and mlaFEDCB.
Discussion
MarA-like proteins are frequently implicated in the development
of clinical resistance to quinolone and tetracycline family
antibiotics40, 41. For example, constitutive MarA production
reduces the rate of killing by norﬂoxacin and oﬂoxacin in E.
coli42. This provides an opportunity for subsequent beneﬁcial
mutations to arise4, 40. Of the MarA target genes, we identiﬁed
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loss of xseA, rather than tolC, had the biggest impact on quino-
lone activity (Fig. 1d). Hence, we demonstrate a direct molecular
link between MarA expression and reduced DNA damage
(Fig. 2). This overlooked feature of the mar system in E. coli is
likely to be widespread; the position and sequence of the marbox
at PxseA is conserved in many enteric bacteria (Fig. 4). Dereg-
ulation of the mar operon is also associated with evolution of
resistance to tetracyclines43. Indeed, clinically relevant levels of
tetracycline resistance have been attributed solely to over-
production of MarA in E. coli44. Interestingly, substantial resis-
tance to some tetracycline family antibiotics is retained in marR
mutants lacking tolC or acrAB22. Hence, the mar regulon must
encode other determinants for drug resistance. Our data show
that the mlaFEDCB operon is of particular importance; the locus
couples MarA to the control of lipid trafﬁcking and outer
membrane integrity (Figs. 1, 3). We note that tetracycline family
antibiotics vary in their properties; doxycycline and minocycline
are more hydrophobic than tetracycline45. Hence, increased
surface hydrophobicity, due to inactivation of mlaFEDCB, ren-
ders cells most sensitive to the former two drugs (Fig. 1d).
Consistent with our interpretation, others have noted a positive
correlation between compound hydrophobicity and resistance
provided by the mar system46, 47.
The potential for cross-talk with other AraC family proteins
complicates the study of gene regulation by MarA19. We show that
both the xseA and mlaFEDCB promoters preferentially bind MarA
rather than SoxS (Supplementary Fig. 10). Furthermore, upregula-
tion of MarA expression activates these promoters even when SoxS
and Rob are present (Supplementary Fig. 3). Even so, we do not
exclude the possibility that MarA targets described here will bind
closely related proteins in some circumstances (Supplementary
Figs. 9, 10). Indeed, the mlaFEDCB locus is a target for RamA in
Klebsiella pneumoniae17. Similarly, of 25 E. coli SoxS targets iden-
tiﬁed using ChIP-exo48, 7 are bound by MarA in this study (ybaO,
acrZ, ybjC, ycgZ, micF, ypeC and yjcB). Surprisingly, genes encoding
transcription factors, including the global regulator FNR, were the
second most common class of MarA targets (Table 1; Fig. 4). This
provides an explanation for the pleiotropic effects of MarA on gene
expression. Furthermore, because ﬁve MarA target genes were also
a target for FNR, responses to oxidative and antibiotic stress must
overlap28, 49. In conclusion, our work identiﬁes previously unrec-
ognised pathways to antibiotic tolerance mediated by MarA-like
regulators. We suggest that the proteins involved are excellent drug
targets; inhibition of XseA and MlaFEDCB should enhance the
efﬁcacy of quinolones and tetracyclines.
Methods
Strains, plasmids and oligonucleotides. ETEC strain H10407 is described by
Crossman et al.27 The E. coli K-12 strains JCB387 and BW25113 are described by
Page et al.50 and Datsenko and Wanner51, respectively. The xseA::kan and mlaE::
kan derivatives of BW25113 were obtained from the Keio collection52 Plasmids
pRW50 and pSR are described by Lodge et al.53 and Kolb et al.54 More detailed
descriptions of strains and plasmids, along with sequences of oligonucleotides, are
provided in Supplementary Table 3.
Chromatin immunoprecipitation and DNA sequencing. Immunoprecipitations
with anti-MarA, anti-MarR and anti-σ70 antibodies were done as described by
Haycocks et al.55 using lysates of bacterial strain H10407 transformed with plasmid
pRGM9818 encoding marA under the control of the tac promoter56. This allowed
us to circumvent repression of the chromosomal mar locus by MarR. Immuno-
precipitations with anti-FLAG were done using lysates of H10407 transformed with
pAMNF (encoding MarR-3xFLAG) or pAMNM (encoding MarR-8xMyc). Lysates
were prepared from log phase cells cultured in LB medium. Anti-σ70 and anti-
FLAG were purchased from Neoclone (Madison, USA) and Sigma, respectively.
Anti-MarA and anti-MarR were a kind gift from Lee Rosner and Bob Martin (NIH,
Bethesda). Libraries were prepared using immunoprecipitated protein–DNA
complexes immobilised with Protein A sepharose. DNA fragments were then blunt
ended, A-tailed and barcoded. This was done using an NEB Quick Blunting and
Ligation Kit, the Klenow fragment (5′–3′ exo-, NEB) and NEXTﬂex ChIP-seq
barcodes (Bioo Scientiﬁc). Following elution of complexes from the Protein A
sepharose, crosslinks were reversed and barcoded libraries were ampliﬁed by PCR.
The number of PCR cycles was determined empirically for each library. After
ampliﬁcation, library concentration was quantiﬁed using Qubit analysis and real-
time PCR. Equimolar library concentrations were pooled and sequenced using an
Illumina MiSeq instrument. Sequencing reads are stored in ArrayExpress under
accession number E-MTAB-5521 and E-MTAB-5591.
Bioinformatic analysis of sequence reads. The Fastq ﬁles obtained after DNA
sequencing were converted into Fastq Sanger format, using FastqGroomer, and
aligned to Genbank reference sequences (FN649414.1, FN649418, FN649417,
FN649416 or FN649415) using BWA for Illumina. The reference sequences cor-
respond to the H10407 chromosome and plasmids p948, p666, p58 and p52,
respectively. The resulting SAM ﬁles were converted to BAM format using SAM-
to-BAM. For each experiment, coverage per base was determined using multi-
BamSummary. Subsequent processing was done using R. Data were normalised to
the same average read depth and mean coverage per base was determined for each
pair of replicates. The immunoprecipitations with anti-MarR were poorly efﬁcient;
enrichment of the marRAB promoter was evident but most peaks were associated
with highly transcribed genes. These data served as a useful control for the anti-
MarA data set; non-speciﬁc signals were removed by subtracting the anti-MarR
signal from the equivalent anti-MarA value. Conversely, the anti-FLAG immu-
noprecipitations, with lysates of H10407 expressing MarR-3xFLAG, were highly
efﬁcient and isolated only the marRAB promoter. To select peaks for MarA or σ70
binding, we used Artemis to generate a coverage plot and selected peaks scoring
>2.7-fold (for MarA) or >3-fold (for σ70) over background. A small number of
peaks were called twice because they oscillated above and below the set threshold.
Such duplications were removed manually. Four peaks for MarA binding were
added manually after visual inspection. The peak centres were set as the centre of
the region passing the cut-off rounded to the nearest integer.
Bioinformatic identiﬁcation of MarA binding sites. After deﬁning the MarA
peak centres, we created a set of genome features in gff ﬁle format. Feature
boundaries were 100 bp either side of each peak centre. The 201 bp DNA sequence
corresponding to each feature was extracted using Artemis and submitted to
MEME to search for motifs. The expected number of sites was set to one
per sequence and the minimum motif width was set to 15 bp. A single statistically
signiﬁcant motif (E-value <1e−12) was recovered and this matched the known
MarA binding consensus. The E-value is derived by MEME, from the motif’s log
likelihood ratio, taking motif length and background DNA sequence into account.
Fig. 3MarA controls outer membrane barrier function via activation of the mlaFEDCB operon. a ChIP-seq data for MarA and σ70 binding at mlaFEDCB. Data
are smoothed in a 100 bp window. b DNA sequence upstream of mlaF (start codon in blue). DNA elements are labelled and arrows indicate orientation.
Transcription start sites identiﬁed in vitro are highlighted by bent arrows. The 5′ end of the mlaF1 and mlaF2 DNA fragments are indicated by inverted black
triangles. c Electrophoretic mobility shift assays with the mlaF1 fragment (+marbox) and the mlaF2 fragment (−marbox). Concentrations of MarA are 0.3,
1.0 and 1.7 μM. d DNAseI footprinting experiment, using the mlaF1 DNA fragment, calibrated with a Maxam–Gilbert GA sequencing ladder. Positions
relative to the xseA transcription start site (+1) are labelled. Concentrations of MarA are 0.3, 1.0, 1.7, 2.4 and 3.3 μM. e Results of in vitro transcription
assays with the mlaF1 DNA fragment cloned in plasmid pSR. The gel is calibrated with a GA sequencing ladder. The RNAI transcript, derived from the pSR
replication origin, acts as an internal control. Concentrations of MarA are 0.3 or 1.0 μM. f β-galactosidase assay with lysates of JCB387 transformed with a
reporter plasmid where lacZ is controlled by either mlaF1 (+marbox) or mlaF2 (−marbox). Error bars show standard deviation (n= 3). g The graph shows
OD650 values for cultures of strain BW25113 mlaE::kan grown with or without 1.0 μg/ml doxycycline. The BW25113 mlaE::kan cells were transformed with
pBR322 derivatives encoding mlaFEDCB under the control of either the mlaF1 fragment (+marbox) or the mlaF2 fragment (−marbox). Error bars show
standard deviation (n= 3). h, i Accumulation of doxycycline or efﬂux of ethidium bromide as a function of time for BW25113 (solid line) or the mlaE::kan
derivative (dashed line). j Percentage absorbance of the aqueous phase at equilibrium after mixing with p-xylene. Data are for BW25113 (solid line) and the
mlaE::kan derivative (dashed line). k The graph shows crystal violet adsorption by BW25113 (solid bar) or the mlaE::kan derivative (open bar). Data are
normalised relative to BW25113 cells. Error bars show standard deviation (n= 3)
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To determine the distance between peak centres for σ70 and MarA, we used the
fetch closest non-overlapping feature tool in Galaxy57. Peaks for σ70 and MarA
described as overlapping were those centred were within 150 bp of each other.
Phylogenetic analysis of the marbox. Excluding E. coli species, we used BLASTp
to search for genomes encoding MarA. We manually removed genomes encoding
MarA with changes in the amino-acid sequence of either DNA recognition helix;
this is indicative of altered DNA binding speciﬁcity. Many of the resulting 161
genomes were derived from closely related strains of the same species. These were
omitted so that 29 representative genomes remained. Phylogeny was determined
using the sequence of the polA gene from each organism and BLASTn pairwise
alignments. We used BLASTn to search the 29 genome sequences for a match to
the 201 bp DNA sequence derived from each MarA ChIP-seq peak. If multiple hits
were obtained from a single genome, only the best match was used. If required,
pairwise alignments were optimised manually to remove alignment gaps within
marbox sequences. If no sequence match was identiﬁed, this was scored as ‘region
absent’. An identiﬁed marbox was scored as ‘conserved’ if it matched either the
equivalent E. coli sequence, or the consensus marbox (5′-gcactaattgctaaa-3′) in at
least 14 of the 15 possible positions. Sites were scored as ‘conserved with mis-
matches’ if the above criteria were satisﬁed at 13 of the 15 marbox positions.
Sequences falling below this threshold we scored as ‘not conserved’.
Identiﬁcation of H10407 MarA targets shared with K-12. To locate regions of
the E. coli K-12 genome equivalent to those in strain H10407, we used BLASTn.
We compared the sequence of the marbox, intergenic region (deﬁned as 200 bp
upstream of the target gene or entire region between convergent genes) and target
gene. Of the 28 shared marboxes, all but 6 were within identical intergenic regions.
Of the six intergenic regions that differed, four contained a single base change and
two had differences in just two positions. None of the intergenic regions contained
insertions or deletions, consistent with identical juxtaposition of promoter ele-
ments and regulator binding sites between strains. Target genes were a minimum
of 97% identical at the nucleotide level and 13 genes had 100% identity.
Proteins. Puriﬁed MarA, SoxS and Rob were a gift from Lee Rosner and Bob
Martin (NIH, Bethesda). RNA polymerase was puriﬁed using a method derived
from Burgess and Jendrisak58. Brieﬂy, E. coli strain MG1655 was grown overnight
in 3 l of LB broth. Cells were harvested by centrifugation and resuspended in 100
ml of lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 2 mM MgCl2, 0.1 mM
DTT, 2 mM EDTA, 1 mM 2-mercaptoethanol, 5% glycerol, 0.2% Triton
X-100 and 0.25 mg/ml lysozyme). One protease inhibitor cocktail tablet (Roche)
was added per 20 ml of buffer. Cell lysis and DNA shearing was done using 4 × 30 s
pulses, at 20% output, with a Misonix XL2020 tip sonicator. Lysates were cleared by
centrifugation at 39,000×g for 45 min at 4 °C. Following ﬁltration (0.45 µm ﬁlter)
Polymin P and ammonium sulphate precipitation were done as described in
Burgess and Jendrisak58. Precipitated protein was resuspended in TGED buffer (10
mM Tris-HCl pH 7.9, 5% glycerol, 0.1 mM EDTA and 0.1 mM DTT) containing
100 mM NaCl and passed through a HiPrep Heparin FF column (GE Healthcare).
The column was washed with 0.1 M NaCl TGED and RNA polymerase was eluted
in TGED using a gradient to 1 M NaCl. RNA polymerase containing fractions were
pooled and protein precipitated using ammonium sulphate. After resuspension in
TGED, RNA polymerase was further puriﬁed using a Mono Q HR column (GE
Healthcare). Column washing and protein elution were as described in the previous
step. RNA polymerase containing fractions were pooled and dialysed against −80 °
C storage buffer (TGED, 0.1 M NaCl, 50% glycerol).
DNA binding and in vitro transcription assays. For EMSA experiments, DNA
fragments were prepared using PCR as described by Shimada et al.59 with oligo-
nucleotides listed in Supplementary Table 3. Protein binding and subsequent
electrophoresis were done as described by Chintakayala et al.60 For footprinting
experiments, DNA fragments were prepared as described by Grainger et al.61
Protein binding, DNA digestion and electrophoresis were done as described by
Singh and Grainger62. Brieﬂy, DNA fragments were labelled at one end using
[γ-32P]-ATP and T4 polynucleotide kinase and used at a ﬁnal concentration of ~10
nM in footprinting reactions. All reactions contained excess of herring sperm DNA
(12.5 µg/ml) as a non-speciﬁc competitor. Our in vitro transcription assays were
done as described by Haycocks et al.55 Brieﬂy, supercoiled pSR plasmid carrying
promoter inserts (16 µg/ml) was pre-incubated with MarA in buffer containing 20
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Fig. 4 Phylogentic footprinting of the MarA regulon. The heatmap illustrates conservation of marboxes identiﬁed by ChIP-seq (x-axis) in the genomes of
different enteric bacteria (y-axis). Dark green indicates conservation of a marbox with a maximum of one mismatch and light green indicates a maximum of
two mismatches. Grey indicates that the intragenic region was identiﬁed but the marbox was poorly conserved or absent. Open boxes represent intergenic
regions that were not identiﬁed in that genome. The evolutionary relationship between the different organisms, determined on the basis of the polA gene
sequence, is indicated by a cladogram
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mM Tris pH 7.9, 5 mM MgCl2, 500 µM DTT, 50 mM KCl, 100 µg/ml BSA, 200 µM
ATP, 200 µM GTP, 200 µM CTP, 10 µM UTP and 5 µCi [α-32P]-UTP. Puriﬁed E.
coli RNA polymerase was added to start reactions. DNAseI digested DNA and
in vitro generated RNA transcripts were analysed on 6% DNA sequencing gels
(molecular dynamics). The results were visualised using a Fuji phosphor screen and
Bio-Rad Molecular Imager FX. Raw gel images are in Supplementary Fig. 11.
β-galactosidase assays. β-galactosidase assays were done as described
previously60, 63 using the protocol of Miller64. All assay values are the mean of three
independent experiments with a standard deviation equivalent to <10% of the
mean β-galactosidase activity. Cells were grown aerobically at 37 °C to mid-log
phase in LB medium unless stated otherwise.
Growth assays and MIC determination. A single colony of each bacterial strain
was used to inoculate 5 ml of LB broth that was incubated overnight at 37 °C. The
OD650 of overnight cultures was recorded so that equivalent OD650 units could be
used for sub-culturing each strain in fresh LB medium. The sub-cultures were then
placed in a shaking incubator at 37 °C and, at 40 min intervals, 200 μl was trans-
ferred to a 96-well plate to measure OD650 units. We used the MIC brothmic
microtitre double dilution method to assess antibiotic sensitivity65. These assays
were done in a ﬁnal volume of 100 μl of LB medium in a 96 well round bottomed
microtitre plate. Each well contained 10 colony forming units of E. coli, 100 μl of
LB medium and antibiotics as required. The microtitre plate was covered with a
sterile lid and kept in a gently shaking incubator for 24 h at 37 °C. The MIC was the
lowest antibiotic concentration that prevented bacterial growth. Results were only
accepted if the observed MIC for the control NCTC E. coli 10418 and ATCC E. coli
25922 strains was within one doubling dilution of the expected result.
Microscopy. Cells were grown in 1.5 ml of LB medium in the presence or absence
of 0.005 µg/ml ciproﬂoxacin for 36 h at 37 °C. Cells were harvested by cen-
trifugation and washed three times with PBS (140 mM NaCl, 2 mM KCl, 8 mM
Na2HPO4, 1.5 mM KH2PO4). After washing, cells were resuspended in 10 μl of PBS
containing Hoechst 33258 (5 µg/ml) and 40% (v/v) glycerol and left at room
temperature for 10 min. Microscope slides were prepared by spreading 5 μl poly-L-
lysine (10 mg/ml; Sigma) onto the centre of a slide. After drying, the slide was
loaded with 5 μl of the cells suspension and a cover slip applied. The slides con-
taining the cells were imaged using a Nikon Eclipse 90i microscope containing a
Nikon Intensilight C-HGFI lamp, Hamamatsu ORCA ER camera (pixel size 6.45
μm) and Nikon Plan Apo VC ×100 Oil immersion lens (Numerical Aperture 1.4).
The magniﬁcation was ×100 and a DAPI ﬁlter set allowed detection of Hoechst
33258-stained nucleoids. Exposure time was 90 ms, the excitation ﬁlter range was
340–380 nm and barrier ﬁlter range was 435–485 nm. Microscopy was done at
room temperature and slides were imaged within 30 min of preparation. Images
were analysed using the Nikon’s NIS elements software.
Pulse ﬁeld gel electrophoresis. Preparation of DNA for PFGE was based on the
method described by Heath et al.66 Overnight cultures of BW25113 and derivative
strains were grown in presence or absence of 0.005 µg/ml ciproﬂoxacin at 37 °C for
36 h. After growth, cells were recovered, washed with PIV buffer (10 mM Tris-HCl
pH 7.6, 1 M NaCl) and suspended in PIV at a ﬁnal OD650 of 1.7 units. The
suspensions were incubated at 37 °C for 10 min and mixed with an equal volume of
1% PFGE grade agarose (Amresco Agarose LF) at 42 °C. Agarose plugs were
prepared by pouring the suspension into PFGE moulds. After solidiﬁcation, plugs
were transferred to EC Lysis buffer (6 mM Tris-HCl pH 7.6, 1 M NaCl, 100 mM
EDTA, 0.2% deoxycholate, 1% N-lauroylsarcosine, 1 mg/ml lysozyme, 20 µg/ml
RNase) and incubated overnight in a gently shaking incubator at 37 °C. Buffer was
removed and plugs were washed ﬁve times with TE buffer (10 mM Tris-HCl, pH
7.5, 1 mM EDTA). After washing, plugs were incubated overnight at 37 °C in ESP
buffer (0.5 M EDTA pH 9.5, 1% N-lauryl sarcosine, 50 µg/ml proteinase K). The
following day, plugs were washed ﬁve times with TE buffer and then stored in TE
buffer at 4 °C until used. PFGE was done over 24 h in 0.5× TBE using a CHEF-DR
II module system. The initial and ﬁnal switch times were set to 60 and 120 s, the
temperature was 14 °C, voltage was 6 V/cm and the included angle was 120°. The
gel was stained using ethidium bromide.
Accumulation and efﬂux assays. Accumulation of doxycycline was measured
using protocols derived from Mortimer and Piddock67. About 10 ml of fresh LB
broth was inoculated with 250 μl of an overnight culture and placed in a shaking
incubator at 37 °C. When the culture had obtained an OD650 of ~0.7 units, the cells
were harvested by centrifugation and resuspended in 10 ml of ice-cold PBS. After
washing, cells were resuspended in PBS with a ﬁnal OD650 value of 20 units. The
suspension was then transferred to a sterile universal container and left to equi-
librate at 37 °C with magnetic stirring. Doxycycline was added to the cell sus-
pension at a ﬁnal concentration of 35 μg/ml. At timed intervals, after the addition
of doxycycline, 500 μl of cell suspension was added to an Eppendorf tube con-
taining 1 ml of ice-cold PBS. After mixing, cells were recovered by centrifugation at
4 °C. Samples were washed with ice-cold PBS to remove residual doxycycline and
stored on ice until the end of the time course. After being resuspended in 1 ml of
100 mM glycine (pH 3), and incubated for 2 h at room temperature, cell debris was
removed by centrifugation and ﬂuorescence was measured. Efﬂux assays were
based on protocols described by Blair et al.68 Cells were initially grown as described
above. After washing with PBS, cells were resuspended in PBS at an OD650 of 0.3
units. Ethidium bromide was added to a ﬁnal concentration of 5 μg/ml and the
efﬂux inhibitor chlorpromazine was added to a concentration of 50 μg/ml69. The
suspension was incubated at 25 °C for 60 min. Once loaded with ethidium bromide,
cells were washed with PBS and resuspended in PBS containing 0.4% v/v glucose to
induce efﬂux.
Hydrocarbon and crystal violet binding assays. Partitioning of cells between
PUM buffer and p-xylene was done as described by Rosenberg et al.38 Crystal violet
binding assays were done as described by Halder et al.39
Data availability. ChIP-seq reads have been deposited in the ArrayExpress data-
base under accession codes E-MTAB-5521 and E-MTAB-5591. The authors declare
that all other data supporting the ﬁndings of the study are available in this article
and its Supplementary Information ﬁles, or from the corresponding author upon
request.
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